From July 6 to 9, 2026, Benin’s health sector underwent a landmark evaluation that could redefine its global standing. The Agence Béninoise du Médicament et des autres produits de Santé (ABMed) was subjected to a rigorous four-day inspection by a team of eight World Health Organization (WHO) experts. This assessment aimed to measure the country’s compliance with international pharmaceutical regulations, covering everything from drug approval processes to market surveillance and clinical trials.
a historic health milestone for Benin
The inspection, conducted in Cotonou, scrutinized every facet of Benin’s regulatory framework. Experts evaluated the ABMed’s legal structure, operational efficiency, and enforcement mechanisms to determine its alignment with WHO’s strictest standards. The findings, presented on July 9, revealed significant progress, positioning the Bénin as a potential candidate for WHO’s Maturity Level 3 certification—a benchmark for robust, self-sufficient pharmaceutical governance.
what does maturity level 3 mean for public health?
Maturity Level 3 signifies that a country’s regulatory authority has achieved full control over its pharmaceutical supply chain, ensuring the availability of safe, effective, and high-quality medicines. For Benin, this status would mean enhanced protection against counterfeit drugs, a stronger local pharmaceutical industry, and greater trust from international partners. The certification also opens doors for regional exports, reinforcing the country’s role as a health security leader in West Africa.
During the results presentation, Professor Benjamin Hounkpatin, Benin’s Minister of Health, hailed the progress as a testament to years of systemic reforms. Since 2017, the government has restructured the former pharmacy directorate into an autonomous agency (ABMed) and strengthened legislation to combat illicit pharmaceutical practices. The minister emphasized the state’s unwavering commitment to supporting ABMed until the certification is fully secured.
a decade of reforms reaching fruition
The journey to this pivotal moment began nearly a decade ago with a bold overhaul of Benin’s health sector. By transforming its regulatory landscape, the country has demonstrated that political will and technical rigor can bridge gaps between local systems and global best practices. If approved, Benin would join Senegal as the second Francophone West African nation to achieve Maturity Level 3—a distinction that underscores its growing influence in continental health governance.
The final decision rests on the ABMed’s ability to address any remaining recommendations from the WHO team. With the evaluation complete, Benin stands on the brink of a new era in public health, where patient safety and pharmaceutical sovereignty are no longer aspirational goals but tangible achievements in progress.
